Beyond Air, Inc. Finite-Lived License Agreements, Gross
Beyond Air, Inc. (XAIR) had Finite-Lived License Agreements, Gross of $966.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedLicenseAgreementsGross · last filed 2026-08-13
- 2026-06-30: Finite-Lived License Agreements, Gross $966.00K.
- 2026-03-31: Finite-Lived License Agreements, Gross $1.02M.
- 2025-12-31: Finite-Lived License Agreements, Gross $1.07M.
- 2025-09-30: Finite-Lived License Agreements, Gross $1.12M.
| Period end | Finite-Lived License Agreements, Gross |
|---|---|
| 2026-06-30 | $966.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.02M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $1.07M 10-Q · filed 2026-02-13 |
| 2025-09-30 | $1.12M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $1.17M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.22M 10-K · filed 2026-06-26 |
| 2024-12-31 | $1.27M 10-Q · filed 2025-02-10 |
| 2024-09-30 | $1.32M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.38M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.43M 10-K · filed 2025-06-20 |
| 2023-03-31 | $1.63M 10-K · filed 2024-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |